Clinical Trial: Clinical Trial to Evaluate the Efficacy of Lacticaseibacillus Rhamnosus CRL1505 in the Prevention of Upper Respiratory Tract Infections in Children

U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07154992) titled 'Clinical Trial to Evaluate the Efficacy of Lacticaseibacillus Rhamnosus CRL1505 in the Prevention of Upper Respiratory Tract Infections in Children' on Aug. 27.

Brief Summary: Randomized, double-blind, placebo-controlled, parallel-group, clinical trial to assess the efficacy of the intake of a probiotic product composed of Lacticaseibacillus rhamnosus CRL1505 strain in reducing or preventing upper respiratory tract infections (URTIs) in a healthy paediatric population.

Study Start Date: Dec. 17, 2024

Study Type: INTERVENTIONAL

Condition: Upper Respiratory Tract Infection Prevention

Intervention: DIETARY_SUPPLEMENT: Probiotic -...